封面
市場調查報告書
商品編碼
1391907

家禽抗生素市場:依產品類型、依給藥方法、配銷通路、地區

Poultry Antibiotic Market, By Product Type, By Mode of Administration, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年,全球家禽抗生素市場規模將達20億美元。預計未來幾年將出現溫和成長,2023 年至 2030 年複合年成長率為 6%。因此,預計到 2030年終市場規模將達到 30 億美元。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 20億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 6.00% 2030年市場規模預測 30億美元
圖 1. 2023 年依地區分類的全球市場佔有率(%)
家禽抗生素市場-IMG1

家禽抗生素主要用於治療商業性或家庭飼養的鳥類(雞、火雞、鵝和鴨)的感染疾病和預防性治療,以獲取其肉、蛋和羽毛。抗生素可以減少進入食品的細菌數量,從而幫助保持雞的健康並提高食品的安全性。家禽抗生素通常對整個雞群給藥,用於治療疾病、預防疾病和促進生長。

市場動態:

雞肉數量的增加、雞蛋和肉類消費的增加、對家禽保健的日益關注、公眾意識的提高以及對安全有效的家禽抗生素的需求不斷增加正在推動全球家禽市場的發展,這些都是預計推動抗生素成長的關鍵因素市場。

例如,2023 年 2 月,法定機構 AgriFutures Australia 宣布了一項針對澳洲價值 41 億美元的家禽業的五年研究、開發和普及計劃。

此外,家禽公司Avec推出永續性憲章,概述家禽業可以改善環境永續性的領域,包括包裝、動物福利和抗生素使用。

本研究的主要特點

  • 本報告詳細分析了全球家禽抗生素市場,並提供了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率(CAGR%)。
  • 它還闡明了各個區隔市場的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據以下參數(例如公司亮點、產品系列、主要亮點、財務實績和策略)介紹了全球家禽抗生素市場的主要企業。
  • 該報告的見解將幫助行銷人員和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
  • 全球家禽抗生素市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球家禽抗生素市場的各種策略矩陣來促進他們的決策。

目錄:

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章家禽抗生素市場-冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章家禽抗生素市場,依產品類型,2018-2030

  • 青黴素
  • 四環素類
  • 大環內酯系列
  • 林可醯胺
  • Aminoglycosides
  • 其他

第6章 2018-2030年家禽抗生素市場(以給藥方式)

  • 口服
  • 注射
  • 其他

第7章家禽抗生素市場,依配銷通路,2018-2030

  • 動物藥房
  • 線上管道
  • 其他

第8章2018-2030年依地區分列的家禽抗生素市場

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章競爭形勢

  • Zoetis Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Merck & Co. Inc.
  • Bayer AG
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Huvepharma
  • Neogen Corporation
  • Nisseiken Co., Ltd.
  • Venkys India Ltd.
  • Inovio Pharmaceuticals, Inc.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5709

The global poultry antibiotic market size is estimated to be US$ 2.0 Billion in 2023. The market is expected to experience a moderate growth rate in the coming years, with a projected CAGR of 6% from 2023 to 2030. This would result in an estimated market size of US$ 3.0 Billion by the end of 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.00% 2030 Value Projection: US$ 3.0 Bn
Figure 1. Global Poultry Antibiotic Market Share (%), By Region, 2023
Poultry Antibiotic Market - IMG1

Poultry antibiotics are primarily used to treat infectious diseases as well as preventative treatment for birds (chickens, turkeys, geese, and ducks) raised commercially or domestically for meat, eggs, and feathers. Antibiotics help make food safe by keeping chickens healthy and reducing bacteria entering the food supply. Antibiotics in poultry are generally administered to the entire flock and are used for the treatment of disease, disease prevention, and growth promotion.

Market Dynamics:

An increase in the population of chickens, a rise in consumption of eggs and meat, a rise in focus on poultry healthcare, an increase in awareness among people, and an increase in demand for safe and effective poultry antibiotics are major factors expected to drive growth of the global poultry antibiotic market.

For instance, in February 2023, AgriFutures Australia, a statutory authority announced a 5-year research, development, and extension plan for Australia's US$ 4.1 billion chicken meat industry.

Moreover, in December 2022, Avec, poultry trading company, announced the launch of its Sustainability Charter, which outlines areas where the poultry industry can improve its environmental sustainability, like packaging, animal welfare, and the use of antibiotics.

Key features of the study:

  • This report provides in-depth analysis of the global poultry antibiotic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global poultry antibiotic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Sante Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Venkys India Ltd., Inovio Pharmaceuticals, Inc, among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global poultry antibiotic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry antibiotic market

Detailed Segmentation:

  • By Product Type:
    • Penicillins
    • Tetracyclines
    • Macrolides
    • Lincosamides
    • Aminoglycosides
    • Others (Fluoroquinolones, etc.)
  • By Mode of Administration:
    • Oral
    • Injection
    • Others
  • By Distribution Channel:
    • Veterinary Pharmacies
    • Online Channel
    • Others (feed stores, etc.)
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Zoetis Inc.
    • Elanco Animal Health
    • Boehringer Ingelheim Animal Health
    • Merck & Co. Inc.
    • Bayer AG
    • Ceva Sante Animale
    • Virbac
    • Vetoquinol S.A.
    • Phibro Animal Health Corporation
    • Huvepharma
    • Neogen Corporation
    • Nisseiken Co., Ltd.
    • Venkys India Ltd.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Poultry Antibiotic, By Product Type
    • Market Poultry Antibiotic, By Mode of Administration
    • Market Poultry Antibiotic, By Distribution Channel
    • Market Poultry Antibiotic, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Poultry Antibiotic Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Poultry Antibiotic Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Penicillins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Tetracyclines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Macrolides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Lincosamides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Aminoglycosides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Poultry Antibiotic Market, By Mode of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Poultry Antibiotic Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Veterinary Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Channel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Poultry Antibiotic Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Huvepharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nisseiken Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Venkys India Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Inovio Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us